-
NMTRQ Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
9 Meters Biopharma (NMTRQ)
Company Profile
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 7.62 mm | 7.62 mm | 7.62 mm | 7.62 mm | 7.62 mm | 7.62 mm |
Cash burn (monthly) | 7.35 mm | 2.47 mm | 4.62 mm | 3.86 mm | 3.25 mm | 3.10 mm |
Cash used (since last report) | 161.52 mm | 54.28 mm | 101.66 mm | 84.93 mm | 71.46 mm | 68.25 mm |
Cash remaining | -153.90 mm | -46.65 mm | -94.03 mm | -77.31 mm | -63.84 mm | -60.63 mm |
Runway (months of cash) | -21.0 | -18.9 | -20.3 | -20.0 | -19.6 | -19.5 |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 6.13 mm |
Total shares | 7.30 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Capital Point | 7.30 mm | $6.13 mm |